Skip to Main content Skip to Navigation
Book sections

Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs

Abstract : The Brazilian experience in producing HIV/AIDS drugs is based on the lawful copying of medicines patented abroad, on a health policy of universal access to antiretrovirals (ARV), and on technological learning, especially in public-sector laboratories through reverse engineering. The information contained in patents has proved to be incomplete and the chemical standards of these molecules are not available in the pharmacopoeias. Chemists at the Rio health ministry’s laboratory have had to partially rediscover the qualitative and quan- titative composition of these drugs. They have thus acquired knowledge on the synthesis processes of the active principles of drugs, which they are now able to transfer to pharmaceutical companies. Apart from copying existing drugs, the laboratory also develops research both in-house and in partnership with universities, to create new molecules. The learning process initiated through copying is thus combined with a research policy.
Complete list of metadata

Cited literature [3 references]  Display  Hide  Download

https://halshs.archives-ouvertes.fr/halshs-02162784
Contributor : Maurice Cassier Connect in order to contact the contributor
Submitted on : Monday, June 24, 2019 - 11:56:04 AM
Last modification on : Thursday, November 18, 2021 - 3:48:04 AM

File

Cassier.pdf
Publication funded by an institution

Identifiers

  • HAL Id : halshs-02162784, version 1

Collections

Citation

Maurice Cassier, Marilena Correa. Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs. Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenge,, 2003. ⟨halshs-02162784⟩

Share

Metrics

Record views

140

Files downloads

312